|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D13.6 |
Benign neoplasm of pancreas
|
D136 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 42.09%
|
18.02%
|
11.02%
|
6.90%
|
5.35%
|
3.63%
|
3.01%
|
2.27%
|
1.43%
|
1.42%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D13.6*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
74183
|
MRI ABD W/O CNTR FLWD CNTR |
853
|
853
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
673
|
674
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
549
|
20,321
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
497
|
498
|
|
82565
|
ASSAY OF CREATININE |
380
|
382
|
|
80053
|
COMPREHEN METABOLIC PANEL |
349
|
349
|
|
A9585
|
GADOBUTROL INJECTION |
334
|
22,409
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
313
|
31,232
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
283
|
283
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
276
|
353
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
213
|
214
|
|
88173
|
CYTOPATH EVAL FNA REPORT |
202
|
217
|
|
86301
|
IMMUNOASSAY TUMOR CA 19-9 |
202
|
202
|
|
G1004
|
CDSM NDSC |
198
|
209
|
|
J7120
|
RINGERS LACTATE INFUSION |
191
|
211
|
|
74181
|
MRI ABDOMEN W/O CONTRAST |
186
|
186
|
|
82150
|
ASSAY OF AMYLASE |
182
|
189
|
|
43242
|
EGD US FINE NEEDLE BX/ASPIR |
163
|
163
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
143
|
21,077
|
|
J3010
|
FENTANYL CITRATE INJECTION |
141
|
166
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D13.6 related to the following DRG Codes:
438-440
|
